Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism Bet v 1 inhibitors(Bet v 1 Protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Conjunctivitis | Preclinical | US | 14 Jan 2021 | |
Conjunctivitis | Preclinical | BE | 14 Jan 2021 | |
Conjunctivitis | Preclinical | CA | 14 Jan 2021 | |
Conjunctivitis | Preclinical | DK | 14 Jan 2021 | |
Conjunctivitis | Preclinical | DE | 14 Jan 2021 | |
Rhinitis, Allergic, Seasonal | Preclinical | DE | 14 Jan 2021 | |
Rhinitis, Allergic, Seasonal | Preclinical | US | 14 Jan 2021 | |
Rhinitis, Allergic, Seasonal | Preclinical | DK | 14 Jan 2021 | |
Rhinitis, Allergic, Seasonal | Preclinical | CA | 14 Jan 2021 | |
Rhinitis, Allergic, Seasonal | Preclinical | BE | 14 Jan 2021 |
Phase 3 | 353 | nlmobosxlk(zwrfaitcil) = mdqjkotzsj cdzaxwuyzh (gnmkvniefo, btrfbjfnkm - gtiydeabts) View more | - | 27 Oct 2022 | |||
Placebo (Placebo Only) | nlmobosxlk(zwrfaitcil) = hnncttdxrp cdzaxwuyzh (gnmkvniefo, hmcmqgtftw - fcpmonuksj) View more |